LSTA:NASDAQ
Lisata Therapeutics Inc
US$3.22
arrow_upward
+0.62%(+0.020) 1 天
4月29日, GMT-4 16:00:00 · USD
search
所有股票代码
1 天
5 天
1 个月
6 个月
年初至今
1 年
5 年
最大
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 LSTA 生成关键数据洞见…
开盘价
US$3.18
最高价
US$3.25
最低价
US$3.12
市值
二九〇八.四〇万
平均成交量
八.四一万
成交量
六.一七万
52 周最高价
US$5.07
52 周最低价
US$1.81
每股收益
-US$1.91
Beta 版
一.一〇
流通股数
九〇三.二〇万
员工人数
二一
新闻报道
来自全网
资料
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022.
In 2019, the FDA granted their product, certepetide, orphan drug status in pancreatic cancer, followed by a Fast track status in 2022. Non-clinical data collected by Lisata and others have demonstrated enhanced delivery of various existing and emerging anti-cancer therapies, including chemotherapies, immunotherapies and RNA-based therapeutics when used with certepetide. Wikipedia
Lisata Therapeutics Inc简介